Silver Book Fact

Fact image

The Impact of Personalized Medicine on Cancer Survival in Years

Munoz, J and R Kurzrock. Targeted Therapy in Rare Cancers: Adopting the orphans. Nat Rev Clin Oncol. 2012; 9(11): 631-42. http://www.ncbi.nlm.nih.gov/pubmed/22965154

Reference

Title
Targeted Therapy in Rare Cancers: Adopting the orphans
Publication
Nat Rev Clin Oncol
Publication Date
2012
Authors
Munoz, J and R Kurzrock
Volume & Issue
Volume 9, Issue 11
Pages
631-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • FDA Cancer Approvals for Aug 2014 to July 2015
     
  • Surgical biopsy for lumps in the breast was found by one study to cost 2 1/2 to 3 times more than image-guided core-needle biopsy ($698 versus $243).  
  • Investments in cancer research and development between 1998 and 2000 has generated 23 million additional healthy years of life and $1.9 trillion of additional social value.  
  • Use of an epidermal growth factor inhibitor in the treatment of metastatic colon cancer patients without the KRAS gene mutation saw survival rates of 15.6 months, compared to 5.6 months…  
  • An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer…